A reverse split with a proxy for dilution, without the ability to uplist, is usually bad juju, and this is why shareholders are concerned. Advanced Cell Technology is a cutting edge stem cell biotech company currently finishing Phase I trails for Macular Degeneration .
http://ift.tt/1vqAofL
http://ift.tt/1vqAofL
No comments:
Post a Comment